Heavy Traffic Can Be Heartbreaking Washington Post, United States - Nov 30, 2008 The best thing is focus on modifiable factors, such as keeping blood pressure and diabetes in check, lowering cholesterol, increasing physical activity and ...
Chicken Soup for the Heart Common Ground, CA - Chicken legs ? a soup staple in certain cultures ? may be packed with proteins that help ease high blood pressure, according to new research from the ...
Doctors: Economic news may raise blood pressure Jerusalem Post, Israel - At its annual conference last week, hypertension experts urged people to get their blood pressure checked and get treatment if necessary. ...
Could OZ Find Its Heart? Wall Street Journal - ... while Australian shares got a lift from indications that the next move from the country's central bank might be to lower interest rates. ...ASX:OZL
Treating High Cholesterol FOXNews - ... have high cholesterol, according to the American Heart Association. And with nearly 40 million taking prescription medication to lower bad cholesterol, ...
* Dollar hits 7-week high of 108.48 yen on lower oil guardian.co.uk, UK - Aug 5, 2008 Asian equity markets took heart from the solid gains, with Japan's Nikkei average jumping 2.6 percent. The dollar was unchanged from late New York trade at ...
Oatmeal keeps expanding GoErie.com, PA - Aug 6, 2008 ... we can choose among several flavors in each of these specialized varieties of Quaker instant oatmeal: Weight Control, Take Heart, Lower Sugar, ...
Maryland doles out $3.1M in heritage tourism grants Bizjournals.com, NC - ...Heart of Chesapeake Country in Dorchester County; Heart of Civil War in Carroll, Frederick and Washington counties; Lower Eastern Shore; ...
Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome) - P Guaglianone, K Chan, E DelaFlor-Weiss, R Hanisch … - Investigational New Drugs, 1994 - Springer ... At lower doses the observed monophasic of biphasic short half ... FM (ed): Cancer treatment
and the heart, p. 92. ... of Southern California, PO Box 33800, Los Angeles ...
Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine - T Sakuragi, K Yanagisawa, Y Shirai, K Dan - Acta Anaesthesiologica Scandinavica, 1999 - Blackwell Synergy ... were lower than the counts after exposure to 1.0% propofol (P? 0.0048, 0.0027 ... identified
strain was inoculated into 5 mL of brain- heart infusion broth ...33800...
Decline of plasma growth hormone binding protein in old age - H Maheshwari - Journal of Clinical Endocrinology & Metabolism, 1996 - Endocrine Soc ... hypothyroidism; malnutrition; history of cancer; heart, liver or kidney impairment;
or ... The combination of low GH secretion and decreased GH action may ...33800-807 ...
High-performance human myocardial two-dimensional electrophoresis database: Edition 1996 U Zimny-Arndt, C Schele, J Prehm, U Miiller-Werdan … - Electrophoresis, 1996 - doi.wiley.com ... our first database issue, we now identified pro- teins with a lower spot intensity. ...
Table 1. List of human heart proteins identified in our laboratory Database ... -
Hormonal carcinogenesis - BE Henderson, HS Feigelson - Carcinogenesis, 2000 - Oxford Univ Press ... Center, 1441 Eastlake Avenue, MS44, PO Box 33800, Los Angeles ... of men with either
high or low levels of ... tamoxifen can reduce the incidence of heart disease is ...
Correlation of Visco-elastic Properties of Large Arteries with Microscopic Structure - JT APTER, M RABINOWITZ, DH CUMMINGS - Circulation Research, 1966 - Am Heart Assoc ... Julia T. Apter is a Special Fellow of the National Heart Institute. ... arterial segments
were supported in the bath by two vertical rods hooked at the lower free ...
Source: Google Scholar
Enlarged Heart Can Lead to Heart Attack
Aggressively lowering blood pressure isn`t enough to prevent heart attacks and strokes in some patients, and now researchers think they know one reason: enlargement of the heart`s main pumping chamber.
The condition is called left ventricular hypertrophy, or LVH, and affects at least 20 percent of Americans with high blood pressure, or up to 12 million people.
Two new studies found that reducing LVH with blood-pressure drugs can further lower the risk of deadly heart trouble in patients whose blood pressure already has been substantially reduced.
"We`ve always known that lowering blood pressure alone in hypertensive patients did not completely reduce the increased risks," said Dr. Peter Okin of Weill Cornell Medical College in New York. "The question was why."
The findings confirm doctors` suspicions that persistent LVH is at least partly to blame, said Okin, who led one of the studies. Another Weill Cornell researcher, Dr. Richard Devereux, led the other. Both appear in Wednesday`s Journal of the American Medical Association.
LVH often is not thought of as a standard risk factor for heart attacks and strokes - partly because, until now, there has been relatively little data showing that reversing LVH could make a difference, according to a JAMA editorial.
Hypertension is the most common cause of LVH, and Okin said all patients with high blood pressure probably should be tested for LVH periodically throughout treatment - something many doctors do not routinely do, he said. Patients whose LVH is not improving or is getting worse should be treated more aggressively, he said.
But American Heart Association spokesman Dr. Daniel Jones contended routine repeat tests to assess LVH in patients with high blood pressure would be premature and too costly. The independent effects of reducing LVH were small in the two studies, and reducing patients` blood pressure should remain the top priority, Jones said.
Okin and Devereux have been paid consultants for Merck & Co., makers of one of the blood pressure drugs involved in the two studies. Merck partly funded both studies.
The studies stem from research on 9,193 men and women with high blood pressure treated with either Merck`s Losartan or the beta blocker atenolol.
In one study, Okin assessed rates of heart attacks, strokes and related deaths over an average of nearly five years. LVH was measured annually by electrocardiograms - inexpensive and widely available tests that measure electrical impulses in the heart.
Patients whose tests showed significant LVH shrinkage were 29 percent less likely to have cardiovascular-related deaths and nonfatal heart attacks and strokes than those whose LVH was unchanged.
Devereux found similar results in a subset of patients evaluated with echocardiograms - a more expensive test that uses sound waves to measure the heart.
